TORNTPHARMPharmaceuticals
Torrent Pharmaceuticals Ltd — Cash Flow Statement
₹4220.20
-0.74%
Torrent Pharmaceuticals Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Capital Expenditure | -611.87 Cr | -432.78 Cr | -573.94 Cr | -202.57 Cr | — |
| End Cash Position | 573.48 Cr | 835.14 Cr | 508.53 Cr | 398.40 Cr | — |
| Beginning Cash Position | 835.14 Cr | 508.53 Cr | 398.40 Cr | 572.56 Cr | — |
| Effect Of Exchange Rate Changes | -8.73 Cr | 8.07 Cr | 21.12 Cr | 0.53 Cr | — |
| Changes In Cash | -252.93 Cr | 318.54 Cr | 30.18 Cr | -174.69 Cr | — |
| Financing Cash Flow | -2.30K Cr | -2.78K Cr | 77.36 Cr | -1.78K Cr | — |
| Interest Paid Cff | -262.22 Cr | -370.96 Cr | -303.02 Cr | -257.72 Cr | — |
| Cash Dividends Paid | -1.08K Cr | -1.02K Cr | -863.04 Cr | -676.89 Cr | — |
| Net Issuance Payments Of Debt | -925.50 Cr | -1.37K Cr | 1.27K Cr | -814.34 Cr | — |
| Net Short Term Debt Issuance | -396.32 Cr | -133.43 Cr | 842.03 Cr | 218.64 Cr | — |
| Short Term Debt Payments | -396.32 Cr | -133.43 Cr | — | — | — |
| Net Long Term Debt Issuance | -529.18 Cr | -1.24K Cr | 423.16 Cr | -1.03K Cr | — |
| Long Term Debt Payments | -529.18 Cr | -1.24K Cr | -971.84 Cr | -1.03K Cr | — |
| Investing Cash Flow | -540.05 Cr | -167.90 Cr | -2.42K Cr | -196.63 Cr | — |
| Interest Received Cfi | 20.26 Cr | 13.12 Cr | 12.90 Cr | 7.24 Cr | — |
| Net Investment Purchase And Sale | 33.79 Cr | 118.10 Cr | -12.98 Cr | -8.09 Cr | — |
| Sale Of Investment | 45.54 Cr | 118.10 Cr | 47.40 Cr | 26.70 Cr | — |
| Purchase Of Investment | -11.75 Cr | 0.00 | -60.38 Cr | -34.79 Cr | — |
| Net PPE Purchase And Sale | -594.10 Cr | -299.12 Cr | -415.23 Cr | -195.78 Cr | — |
| Sale Of PPE | 17.77 Cr | 133.66 Cr | 158.71 Cr | 6.79 Cr | — |
| Purchase Of PPE | -611.87 Cr | -432.78 Cr | -573.94 Cr | -202.57 Cr | — |
| Operating Cash Flow | 2.59K Cr | 3.27K Cr | 2.37K Cr | 1.80K Cr | — |
| Taxes Refund Paid | -602.82 Cr | -498.10 Cr | -398.07 Cr | -421.02 Cr | — |
| Change In Working Capital | -480.93 Cr | 418.08 Cr | -18.20 Cr | -351.85 Cr | — |
| Change In Other Current Liabilities | 93.78 Cr | -17.58 Cr | 93.11 Cr | -65.30 Cr | — |
| Change In Payable | -277.73 Cr | 413.55 Cr | -58.02 Cr | -392.37 Cr | — |
| Change In Inventory | -262.18 Cr | -49.43 Cr | 255.71 Cr | 218.88 Cr | — |
| Change In Receivables | -34.80 Cr | 71.54 Cr | -309.00 Cr | -113.06 Cr | — |
| Other Non Cash Items | 232.12 Cr | 253.70 Cr | 318.66 Cr | 732.61 Cr | — |
| Provisionand Write Offof Assets | 1.77 Cr | 7.08 Cr | 2.27 Cr | 0.90 Cr | — |
| Depreciation And Amortization | 794.93 Cr | 795.30 Cr | 702.03 Cr | 661.93 Cr | — |
| Amortization Cash Flow | 542.71 Cr | 542.92 Cr | 476.56 Cr | 415.70 Cr | — |
| Depreciation | 252.22 Cr | 252.38 Cr | 225.47 Cr | 246.23 Cr | — |
| Gain Loss On Investment Securities | -16.73 Cr | -17.99 Cr | -19.51 Cr | -10.14 Cr | — |
| Net Foreign Currency Exchange Gain Loss | -14.70 Cr | -57.09 Cr | -49.15 Cr | -36.40 Cr | — |
| Gain Loss On Sale Of PPE | -1.34 Cr | 0.02 Cr | -21.62 Cr | 0.82 Cr | — |
| Net Income From Continuing Operations | 2.67K Cr | 2.35K Cr | 1.85K Cr | 1.23K Cr | — |
| Free Cash Flow | 1.97K Cr | 2.83K Cr | 1.79K Cr | 1.60K Cr | — |
| Repayment Of Debt | -925.50 Cr | -1.37K Cr | -971.84 Cr | -1.03K Cr | — |
| Issuance Of Debt | — | 0.00 | 1.40K Cr | 0.00 | 895.00 Cr |
| Long Term Debt Issuance | — | 0.00 | 1.40K Cr | 0.00 | 895.00 Cr |
| Net Business Purchase And Sale | — | 0.00 | -2.00K Cr | 0.00 | — |
| Purchase Of Business | — | 0.00 | -2.00K Cr | 0.00 | — |
| Other Cash Adjustment Outside Changein Cash | — | — | 58.83 Cr | — | — |
| Common Stock Dividend Paid | — | — | — | — | -338.00 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Torrent Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.